Skeletal-muscle index predicts survival after percutaneous transhepatic biliary drainage for obstructive jaundice due to perihilar cholangiocarcinoma

[1] Razumilava N(2014)Cholangiocarcinoma Lancet 383 2168-2179

[2] Gores GJ(2014)Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 1268-1289

[3] Bridgewater J(2018)Cholangiocarcinoma—evolving concepts and therapeutic strategies Nat Rev Clin Oncol 15 95-111

[4] Galle PR(2013)Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma J Gastroenterol Hepatol 28 593-607

[5] Khan SA(2018)Percutaneous metallic stent placement for palliative management of malignant biliary hilar obstruction Korean J Radiol 19 597-605

[6] Rizvi S(2018)Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: a multicenter trial J Hepatol 68 970-977

[7] Khan SA(2014)Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma Ann Surg Oncol 21 3638-3645

[8] Hallemeier CL(2019)Predictors of recurrent biliary obstruction following percutaneous uncovered metal stent insertion in patients with distal malignant biliary obstruction: an analysis using a competing risk model Cardiovasc Intervent Radiol 42 276-282

[9] Kelley RK(2016)Percutaneous transhepatic biliary stent implantation for obstructive jaundice of perihilar cholangiocarcinoma: a prospective study on predictors of stent patency and survival in 92 patients J Vasc Interv Radiol 27 1047-1055.e2

[10] Gores GJ(2014)A new clinically based staging system for perihilar cholangiocarcinoma Am J Gastroenterol 109 1881-1890

[1] Razumilava N(2014)Cholangiocarcinoma Lancet 383 2168-2179

[2] Gores GJ(2014)Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 1268-1289

[3] Bridgewater J(2018)Cholangiocarcinoma—evolving concepts and therapeutic strategies Nat Rev Clin Oncol 15 95-111

[4] Galle PR(2013)Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma J Gastroenterol Hepatol 28 593-607

[5] Khan SA(2018)Percutaneous metallic stent placement for palliative management of malignant biliary hilar obstruction Korean J Radiol 19 597-605

[6] Rizvi S(2018)Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: a multicenter trial J Hepatol 68 970-977

[7] Khan SA(2014)Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma Ann Surg Oncol 21 3638-3645

[8] Hallemeier CL(2019)Predictors of recurrent biliary obstruction following percutaneous uncovered metal stent insertion in patients with distal malignant biliary obstruction: an analysis using a competing risk model Cardiovasc Intervent Radiol 42 276-282

[9] Kelley RK(2016)Percutaneous transhepatic biliary stent implantation for obstructive jaundice of perihilar cholangiocarcinoma: a prospective study on predictors of stent patency and survival in 92 patients J Vasc Interv Radiol 27 1047-1055.e2

[10] Gores GJ(2014)A new clinically based staging system for perihilar cholangiocarcinoma Am J Gastroenterol 109 1881-1890